Bcr encodes a GTPase-activating protein for p21rac. 1991

D Diekmann, and S Brill, and M D Garrett, and N Totty, and J Hsuan, and C Monfries, and C Hall, and L Lim, and A Hall
Chester Beatty Beatty Laboratories, Institute of Cancer Research, London, UK.

More than thirty small guanine nucleotide-binding proteins related to the ras-encoded oncoprotein, termed Ras or p21ras, are known. They regulate many fundamental processes in all eukaryotic cells, such as growth, vesicle traffic and cytoskeletal organization. GTPase-activating proteins (GAPs) accelerate the intrinsic rate of GTP hydrolysis of Ras-related proteins, leading to down-regulation of the active GTP-bound form. For p21ras, two GAP proteins are known, rasGAP and the neurofibromatosis (NF1) gene product. There is evidence that rasGAP may also be a target protein for regulation by Ras and be involved in downstream signalling. We have purified a GAP protein for p21rho, which is involved in the regulation of the actin cytoskeleton. Partial sequencing of rhoGAP reveals significant homology with the product of the bcr (breakpoint cluster region) gene, the translocation breakpoint in Philadelphia chromosome-positive chronic myeloid leukaemias. We show here that the carboxy-terminal domains of the bcr-encoded protein (Bcr) and of a Bcr-related protein, n-chimaerin, are both GAP proteins for the Ras-related GTP-binding protein, p21rac. This result suggest that Bcr could be a target for regulation by Rac and has important new implications for the role of bcr translocations in leukaemia.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D051562 Proto-Oncogene Proteins c-bcr A serine-threonine kinase that contains a C2 DOMAIN and PLECKSTRIN HOMOLOGY DOMAIN. It also has activity as a GTPASE-ACTIVATING PROTEIN for RAC1 PROTEIN and CDC42 PROTEIN. It functions as a negative regulator of CELL PROLIFERATION and NEOPLASTIC CELL TRANSFORMATION and is commonly fused with cellular abl protein to form BCR-ABL FUSION PROTEINS in PHILADELPHIA CHROMOSOME positive LEUKEMIA patients. bcr Proto-Oncogene Proteins,c-bcr Proteins,Breakpoint Cluster Region Protein,Proto-Oncogene Protein bcr,Proto-Oncogene Protein c-bcr,c-bcr Proto-Oncogene Proteins,Proto Oncogene Protein bcr,Proto Oncogene Protein c bcr,Proto Oncogene Proteins c bcr,Proto-Oncogene Proteins, bcr,Proto-Oncogene Proteins, c-bcr,bcr Proto Oncogene Proteins,c bcr Proteins,c bcr Proto Oncogene Proteins,c-bcr, Proto-Oncogene Protein,c-bcr, Proto-Oncogene Proteins

Related Publications

D Diekmann, and S Brill, and M D Garrett, and N Totty, and J Hsuan, and C Monfries, and C Hall, and L Lim, and A Hall
February 1995, European journal of biochemistry,
D Diekmann, and S Brill, and M D Garrett, and N Totty, and J Hsuan, and C Monfries, and C Hall, and L Lim, and A Hall
October 2008, International journal of molecular medicine,
D Diekmann, and S Brill, and M D Garrett, and N Totty, and J Hsuan, and C Monfries, and C Hall, and L Lim, and A Hall
May 1993, The Journal of biological chemistry,
D Diekmann, and S Brill, and M D Garrett, and N Totty, and J Hsuan, and C Monfries, and C Hall, and L Lim, and A Hall
August 2011, Molecular biology reports,
D Diekmann, and S Brill, and M D Garrett, and N Totty, and J Hsuan, and C Monfries, and C Hall, and L Lim, and A Hall
July 2020, Translational psychiatry,
D Diekmann, and S Brill, and M D Garrett, and N Totty, and J Hsuan, and C Monfries, and C Hall, and L Lim, and A Hall
February 1993, The Journal of biological chemistry,
D Diekmann, and S Brill, and M D Garrett, and N Totty, and J Hsuan, and C Monfries, and C Hall, and L Lim, and A Hall
October 2012, Journal of cell science,
D Diekmann, and S Brill, and M D Garrett, and N Totty, and J Hsuan, and C Monfries, and C Hall, and L Lim, and A Hall
May 1995, The Journal of biological chemistry,
D Diekmann, and S Brill, and M D Garrett, and N Totty, and J Hsuan, and C Monfries, and C Hall, and L Lim, and A Hall
September 1993, Nature,
D Diekmann, and S Brill, and M D Garrett, and N Totty, and J Hsuan, and C Monfries, and C Hall, and L Lim, and A Hall
December 2009, The Journal of biological chemistry,
Copied contents to your clipboard!